Baş Boyun Kanserlerinde Görülen Paraneoplastik Sendromlar
Özet
Paraneoplastik sendromlar, tümörlerin hormon, peptit veya sitokin salgılaması ya da immün çapraz reaktivite sonucu oluşan, kitle etkisi veya metastazla doğrudan ilişkili olmayan sistemik bozukluklardır. Baş boyun kanserlerinde nadir görülmekle birlikte, en sık skuamöz hücreli karsinomla ilişkilendirilir. Bu sendromlar endokrin, dermatolojik, hematolojik, nörolojik ve oküler sistemleri etkileyebilir. Endokrin alt türünde en yaygın durumlar Uygunsuz ADH sendromu, Cushing sendromu ve hiperkalsemidir. Dermatolojik olarak Akantozis nigrikans, Dermatomiyozit ve Bazex sendromu gibi lezyonlar baş boyun tümörlerine eşlik edebilir. Hematolojik bulgular genellikle ileri evre hastalıkta saptanırken, nörolojik paraneoplastik sendromlar (örneğin paraneoplastik serebellar dejenerasyon ve Lambert-Eaton sendromu) çoğunlukla malignite tanısından önce belirti gösterir. Oftalmolojik alanda ise kanser ilişkili retinopati ve optik nörit gibi nadir oküler sendromlar görülebilir. Paraneoplastik sendromlar, gizli tümörlerin erken teşhisine olanak tanıdığı için klinik açıdan kritik öneme sahiptir. Tanı ve tedavi süreci, multidisipliner bir yaklaşım gerektirir; çünkü her bir durumun altında yatan primer maligniteye göre tercih edilen tedavi yöntemi değişkenlik gösterir.
Paraneoplastic syndromes are systemic disorders arising from tumor secretion of hormones, peptides, or cytokines, or from immune cross-reactivity, rather than direct mass effect or metastasis. Although rarely observed in head and neck cancers, they are most frequently associated with squamous cell carcinoma. These syndromes can affect endocrine, dermatological, hematological, neurological, and ocular systems. Within the endocrine subgroup, the most common manifestations include the Syndrome of Inappropriate ADH, Cushing syndrome, and hypercalcemia. Dermatological presentations may feature conditions like Acanthosis nigricans, Dermatomyositis, and Bazex syndrome accompanying head and neck tumors. While hematological findings typically present during advanced disease stages, neurological paraneoplastic syndromes—such as paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome—frequently manifest before the underlying malignancy is diagnosed. In ophthalmology, rare ocular syndromes like cancer-associated retinopathy and optic neuritis can occur. Paraneoplastic syndromes are clinically crucial as they often facilitate the early detection of silent malignancies. Diagnosis and management necessitate a multidisciplinary approach, as the optimal treatment strategy varies depending on the specific primary tumor involved.
Referanslar
Ferlito A, Rinaldo A. Paraneoplastic syndromes in patients with cancer of the larynx and hypopharynx. Ann Otol Rhinol Laryngol. 2007 Jul;116(7):502-13. doi: 10.1177/000348940711600705. PMID: 17727081.
Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc. 2010 Sep;85(9):838-54. doi: 10.4065/mcp.2010.0099. Erratum in: Mayo Clin Proc. 2011 Apr;86(4):364. Dosage error in article text. PMID: 20810794; PMCID: PMC2931619.
Talmi YP, Hoffman HT, McCabe BF. Syndrome of inappropriate secretion of arginine vasopressin in patients with cancer of the head and neck. Ann Otol Rhinol Laryngol 1992;101:946–9. PMID: 1332568 DOI: 10.1177/000348949210101111
Moses AM, Miller M, Streeten DH. Pathophysiologic and pharmacologic alterations in the release and action of ADH. Metabolism. 1976 Jun;25(6):697-721. doi: 10.1016/0026-0495(76)90067-6. PMID: 818477.
Ferlito A, Rinaldo A, Devaney KO (1997) Syndrome of inappropriate antidiuretic hormone secretion associated with head and neck cancers: review of the literature. Ann Otol Rhinol Laryngol 106:878–883 PMID: 9342988 DOI: 10.1177/000348949710601014
Zohar Y, Talmi YP, Finkelstein Y, Nobel M, Gafter U. Syndrome of inappropriate antidiuretic hormone secretion in cancer of the head and neck. Ann Otol Rhinol Laryngol 1991;100:341–4. PMID: 2018296 DOI: 10.1177/000348949110000415
Imura H, Matsukura S, Yamamoto H, Hirata Y, Nakai Y. Studies on ectopic ACTH-producing tumors. II. Clinical and biochemical features of 30 cases. Cancer. 1975 May;35(5):1430-7. doi: 10.1002/1097-0142(197505)35:5<1430::aid-cncr2820350529>3.0.co;2-o. PMID: 164276.
Bishop JW, Osamura RY, Tsutsumi Y. Multiple hormone production in an oat cell carcinoma of the larynx. Acta Pathol Jpn. 1985 Jul;35(4):915-23. doi: 10.1111/j.1440-1827.1985.tb00633.x. PMID: 2416185.
Nasser A, Purgina B, Laurie S. Paraneoplastic manifestations of salivary gland tumours: A case report and review. Oral Oncol. 2020 Apr;103:104582. doi: 10.1016/j.oraloncology.2020.104582. Epub 2020 Feb 13. PMID: 32061536.
Tan KC, Nicholls J, Kung AW, Leong L, Lam KS. Unusual endocrine presentations of nasopharyngeal carcinoma. Cancer. 1996 May 15;77(10):1967-72. doi: 10.1002/(SICI)1097-0142(19960515)77:10<1967::AID-CNCR1>3.0.CO;2-E. PMID: 8640657.
Barbosa SL, Rodien P, Leboulleux S, Niccoli-Sire P, Kraimps JL, et. al. (2005) Groupe d’Etude des Tumeurs Endocrines. Ectopic adrenocorticotropic hormone-syndrome in medullary carcinoma of the thyroid: a retrospective analysis and review of the literature. Thyroid 15:618–623. PMID: 16029131 DOI: 10.1089/thy.2005.15.618
Nimalasena S, Freeman A, Harland S. Paraneoplastic Cushing’s syndrome in prostate cancer: a difficult management problem. BJU Int. 2008;101: 424-427. PMID: 18070179 DOI: 10.1111/j.1464-410X.2007.07294.x
Ralston SH, Gallacher SJ, Patel U, Campbell J, Boyle IT. Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients. Ann Intern Med. 1990 Apr 1;112(7):499-504. doi: 10.7326/0003-4819-112-7-499. PMID: 2138442.
Penel N, Berthon C, Everard F, Neu JC, Clisant S, N’guyen M, et al. Prognosis of hypercalcemia in aerodigestive tract cancers: study of 136 recent cases. Oral Oncol 2005;41:884–9. PMID: 16043379 DOI: 10.1016/j.oraloncology.2005.04.013
Rinaldo A, Coca-Pelaz A, Silver CE, Ferlito A. Paraneoplastic Syndromes Associated with Laryngeal Cancer. Adv Ther. 2020 Jan;37(1):140-154. doi: 10.1007/s12325-019-01160-9. Epub 2019 Dec 4. PMID: 31802393; PMCID: PMC6979447.
Bhalang K, Kafrawy AH, Miles DA. Immunohistochemical study of the expression of human chorionic gonadotropin-beta in oral squamous cell carcinoma. Cancer. 1999 Feb 15;85(4):757-62. PMID: 10091751.
Hedström J, Grenman R, Ramsay H, Finne P, Lundin J, Haglund C, Alfthan H, Stenman UH. Concentration of free hCGbeta subunit in serum as a prognostic marker for squamous-cell carcinoma of the oral cavity and oropharynx. Int J Cancer. 1999 Oct 22;84(5):525-8. doi: 10.1002/(sici)1097-0215(19991022)84:5<525::aid-ijc14>3.0.co;2-q. PMID: 10502732.
Scholl PD, Jurco S, Austin JR. Ectopic production of beta-HCG by a maxillary squamous cell carcinoma. Head Neck. 1997 Dec;19(8):701-5. doi: 10.1002/(sici)1097-0347(199712)19:8<701::aid-hed8>3.0.co;2-9. PMID: 9406749.
Turner JH, Ross H, Richmon J. Secretion of beta-HCG from squamous cell carcinomas of the head and neck. Otolaryngol Head Neck Surg. 2010 Jul;143(1):169-70. doi: 10.1016/j.otohns.2010.02.036. Epub 2010 May 14. PMID: 20620641.
Ferlito A, Elsheikh MN, Manni JJ, Rinaldo A. Paraneoplastic syndromes in patients with primary head and neck cancer. Eur Arch Otorhinolaryngol. 2007 Mar;264(3):211-22. doi: 10.1007/s00405-006-0217-5. Epub 2007 Jan 6. PMID: 17206403.
Oppolzer G, Schwarz T, Zechner G, Gschnait F. Acanthosis nigricans bei Plattenepithelcarcinom des Larynx [Acanthosis nigricans in squamous cell carcinoma of the larynx]. Z Hautkr. 1986 Sep 1;61(17):1229-37. German. PMID: 3776278.
Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003 Sep 20;362(9388):971-82. doi: 10.1016/S0140-6736(03)14368-1. PMID: 14511932.
Nindra U, Nguyen K, Hong J, Bray V, Moylan E. Concurrent Paraneoplastic Dermatomyositis and Acquired C1 Esterase Inhibitor Deficiency in Primary Laryngeal Small Cell Carcinoma. Case Rep Oncol. 2021 Dec 23;14(3):1806-1813. doi: 10.1159/000520383. PMID: 35111013; PMCID: PMC8787545.
Klukas J, Pudszuhn A, Kusch K, Obermueller T, Hofmann VM. Dermatomyositis als paraneoplastisches Syndrom bei Kopf-Hals-Malignomen: Fallserie & Literaturreview [Dermatomyositis as a paraneoplastic syndrome of head-neck-cancer: Case series & literature review]. Laryngorhinootologie. 2021 Jul;100(7):542-549. German. doi: 10.1055/a-1408-6551. Epub 2021 Apr 27. PMID: 33906244.
Roy B, Lipner SR. A Review of Nail Changes in Acrokeratosis Paraneoplastica (Bazex Syndrome). Skin Appendage Disord. 2021 Apr;7(3):163-172. doi: 10.1159/000513828. Epub 2021 Mar 2. PMID: 34055903; PMCID: PMC8138189.
Lechien JR, Khalife M, Saussez S. Acrokeratosis paraneoplastica (Bazex syndrome). Ear Nose Throat J. 2017 Oct-Nov;96(10-11):413-414. doi: 10.1177/0145561317096010-1119. PMID: 29121372.
Adelman ML, Ho QA, Agrawal A. Bazex syndrome in a patient with head and neck malignancy. JAAPA. 2018 Jun;31(6):30-33. doi: 10.1097/01.JAA.0000532114.67884.94. PMID: 29846313.
Vaynshtok PM, Tian F, Kaffenberger BH. Acitretin amelioration of Acrokeratosis Paraneoplastica (Bazex Syndrome) in cases of incurable squamous cell carcinoma of the hypopharynx. Dermatol Online J. 2016 Sep 15;22(9):13030/qt8n96v45x. PMID: 28329620.
Cohen PR. Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007 Jul 26;2:34. doi: 10.1186/1750-1172-2-34. PMID: 17655751; PMCID: PMC1963326.
Cohen PR, Holder WR, Tucker SB, Kono S, Kurzrock R (1993) Sweet syndrome in patients with solid tumors. Cancer 72:2723–2731. PMID: 8402496 DOI: 10.1002/1097-0142(19931101)72:9<2723::aid-cncr2820720933>3.0.co;2-f
Giménez-Arnau A, Carles J, Pla-Ferrer C, Barranco CM, Fontané J, Camarasa JG. Sweet's syndrome and malignancy: a case associated with multiple oral squamous-cell carcinoma. Dermatology. 1996;193(2):154-5. doi: 10.1159/000246236. PMID: 8884158.
Lal G, Brennan TV, Hambleton J, Clark OH (2003) Coagulopathy, marantic endocarditis, and cerebrovascular accidents as paraneoplastic features in medullary thyroid cancer—case report and review of the literature. Thyroid 13:601–605
Maalej M, Ladgham A, Ennouri A, Ben Attia A, Cammoun M, Ellouze R (1985) The paraneoplastic syndrome in nasopharynx cancer. 32 cases. Presse Med 14:471–474
Albert ML, Austin LM, Darnell RB. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann Neurol. 2000 Jan;47(1):9-17. PMID: 10632096.
Garcin R, Lapresle J (1956) Sur un cas d’atrophie c r belleuse corticale subaigue en relation avec un pith lioma du larynx. Arch Path 62:399–402
Imai T, Shinohara K, Uchino K, Okuma H, Maki F, Hiruma K, Ariizumi Y, Yamano Y. Paraneoplastic cerebellar degeneration with anti-Yo antibodies and an associated submandibular gland tumor: a case report. BMC Neurol. 2022 May 2;22(1):165. doi: 10.1186/s12883-022-02684-4. PMID: 35501715; PMCID: PMC9059384.
Ayas ZÖ, Uncu G. A Rare Coexistence of Paraneoplastic Cerebellar Degeneration: Papillary Thyroid Carcinoma. Curr Oncol. 2021 Jan 19;28(1):560-564. doi: 10.3390/curroncol28010055. PMID: 33477892; PMCID: PMC7903265.
Ivanovski T, Miralles F. Lambert-Eaton Myasthenic syndrome: early diagnosis is key. Degener Neurol Neuromuscul Dis. 2019 May 13;9:27-37. doi: 10.2147/DNND.S192588. PMID: 31191084; PMCID: PMC6524763.
Fontanel JP, Betheuil MJ, Sénéchal G, Haguenau M. Un cas de syndrome de Lambert-Eaton secondaire à un épithélioma laryngé [A case of Lambert-Eaton syndrome due to a laryngeal epithelioma]. Ann Otolaryngol Chir Cervicofac. 1973 Apr-May;90(4):314-7. French. PMID: 4753178.
Takasugi J, Shimamura M, Koda T, Kishikawa T, Hanamoto A, Inohara H, Sato K, Morii E, Motomura M, Sakaguchi M, Nakatsuji Y, Mochizuki H. Paraneoplastic Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome Associated with Neuroendocrine Carcinoma of the Oropharynx. Intern Med. 2018 Feb 15;57(4):587-590. doi: 10.2169/internalmedicine.9333-17. Epub 2017 Nov 1. PMID: 29093415; PMCID: PMC5849558.
Parrado-Carrillo A, Alcubierre R, Camós-Carreras A, Sanchez-Dalmau BF. Paraneoplastic syndromes in ophthalmology. Arch Soc Esp Oftalmol (Engl Ed). 2022 Mar 12:S2173-5794(22)00052-4. doi: 10.1016/j.oftale.2022.03.006. Epub ahead of print. PMID: 35292226.
Adamus G, Ren G, Weleber RG. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol. 2004 Jun 4;4:5. doi: 10.1186/1471-2415-4-5. PMID: 15180904; PMCID: PMC446200.
Hoh ST, Teh M, Chew SJ. Paraneoplastic optic neuropathy in nasopharyngeal carcinoma--report of a case. Singapore Med J. 1991 Apr;32(2):170-3. PMID: 2042083.
Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol. 2001 Feb;49(2):146-54. PMID: 11220734.
